Amino Acid Residues 721–729 are Required for Full Factor VIII Activity
- 1 December 1995
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 234 (3) , 773-779
- https://doi.org/10.1111/j.1432-1033.1995.773_a.x
Abstract
Recombinant two-chain factor VIII, from which the B domain had been deleted, was expressed in Chinese hamster ovary cells. In addition to the major product, three minor factor VIII forms were isolated. The A2 domains generated by thrombin cleavage showed different electrophoretic mobilities. Peptide mapping of the A2 domains showed that two of the factor VIII forms had the expected C-terminus of the heavy chain at Arg740 [FVIII-(1-740)] and that the other factor VIII forms had C-termini at Tyr729 [FVIII-(1-729)] or Glu720 [FVIII-(1-720)]. The major FVIII-(1-740) form, FVIII-(1-729), and FVIII-(1-720) contained sulfated tyrosine residues at Tyr718, Tyr719 and Tyr723. The minor FVIII-(1-740) form was shown to lack sulfation at these positions. The specific clotting activity was approximately 1 x 10(4) U/mg for FVIII-(1-740) (both forms) and FVIII-(1-729), but twofold lower for FVIII-(1-720). A time study of thrombin activation showed that FVIII-(1-720) was activated slower than FVIII-(1-740), FVIII-(1-729) and plasma-derived factor VIII. Partially sulfated FVIII-(1-740) was activated at the same rate as the fully sulfated FVIII-(1-740). The equilibrium dissociation constant for binding of factor VIII to inactivated immobilized thrombin was the same for all factor VIII forms, showing that the slower activation of FVIII-(1-720) was not due to a lower affinity for the anion-binding exosite in thrombin.Keywords
This publication has 32 references indexed in Scilit:
- Biological activity of recombinant factor VIII variants lacking the central B‐domain and the heavy‐chain sequence Lys713‐Arg740: discordant in vitro and in vivo activityBritish Journal of Haematology, 1993
- Determination of sulfated peptides via prompt fragmentation by UV matrix‐assisted laser desorption/ionization mass spectrometryRapid Communications in Mass Spectrometry, 1993
- Heterogeneity in the tyrosine sulfation Chinese hamster ovary cell produced recombinant FVIIIBiochemistry, 1991
- Characterization of sites of tyrosine sulfation in proteins and criteria for predicting their occurrenceBiochemical and Biophysical Research Communications, 1986
- The size of human factor VIII heterodimers and the effects produced by thrombinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Assay of Factor VIII:C with a Chromogenic SubstrateScandinavian Journal of Haematology, 1984
- Molecular cloning of a cDNA encoding human antihaemophilic factorNature, 1984
- Structure of human factor VIIINature, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970